glp 1 eli lilly says its experimental GLP-1 pill better than Novo's Rybelsus in diabetes study Trump low-cost GLP-1 plan a

Authors: Thomas Kruse, Jakob Lerche Hansen, Kirsten Dahl, Lauge Schffer, Ulrich Sensfuss, Christian Poulsen, Morten Schlein, Ann Maria Kruse Hansen, Claus Bekker Jeppesen, Charlotta Dornonville de la Cour, Trine Ryberg Clausen, Eva Johansson, Simone Fulle, Rikke Bjerring Skyggebjerg, Kirsten Raun URL: This paper details the medicinal chemistry efforts that led to the design and synthesis of cagrilintide, a long-acting amylin analogue for the treatment of obesity

doi: 10.1016/s0368-2315(05)82888-1

PubMed laboratory research record [PMID: 19105590] PubMed record related to this compound for laboratory literature review

*Correspondence: Bin Chen [email protected] This article was submitted to Food Chemistry, a section of the journal Frontiers in Nutrition Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers